Denali Therapeutics Inc.

Connor, Clark & Lunn Investment Management Ltd. DNLI

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/12/2026

Shares

18,556

Value ($000)

477

Weight

0.0%

2020 Q4 - 2026 Q2 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/12/2026	477	0.0%	18,556	6/30/2026
2022 Q4	2/10/2023	1,699	0.0%	61,096	12/31/2022
2022 Q3	11/10/2022	3,454	0.0%	112,532	9/30/2022
2021 Q2	8/12/2021	1,568	0.0%	19,993	6/30/2021
2021 Q1	5/13/2021	2,164	0.0%	37,906	3/31/2021
2020 Q4	2/16/2021	1,648	0.0%	19,677	12/31/2020